136 related articles for article (PubMed ID: 8419351)
1. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin.
Lawson JH; Butenas S; Ribarik N; Mann KG
J Biol Chem; 1993 Jan; 268(2):767-70. PubMed ID: 8419351
[TBL] [Abstract][Full Text] [Related]
2. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa.
Rao LV; Rapaport SI; Hoang AD
Blood; 1993 May; 81(10):2600-7. PubMed ID: 8490170
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of human factor VIIa-tissue factor by antithrombin III-heparin is enhanced by factor X on a human bladder carcinoma cell line.
Hamamoto T; Foster DC; Kisiel W
Int J Hematol; 1996 Jan; 63(1):51-63. PubMed ID: 8713577
[TBL] [Abstract][Full Text] [Related]
4. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa.
Kondo S; Kisiel W
Thromb Res; 1987 Apr; 46(2):325-35. PubMed ID: 3496682
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
6. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity.
Rao LV; Nordfang O; Hoang AD; Pendurthi UR
Blood; 1995 Jan; 85(1):121-9. PubMed ID: 7803789
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
Lormeau JC; Herault JP; Herbert JM
Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
[TBL] [Abstract][Full Text] [Related]
9. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor.
Jesty J; Lorenz A; Rodriguez J; Wun TC
Blood; 1996 Mar; 87(6):2301-7. PubMed ID: 8630391
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of factor XIa by antithrombin III.
Soons H; Janssen-Claessen T; Tans G; Hemker HC
Biochemistry; 1987 Jul; 26(15):4624-9. PubMed ID: 3499176
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of factor VIIa/tissue factor by antithrombin III and tissue factor pathway inhibitor.
Broze GJ; Likert K; Higuchi D
Blood; 1993 Sep; 82(5):1679-81. PubMed ID: 8364216
[No Abstract] [Full Text] [Related]
13. Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa.
Martínez-Martínez I; Ordóñez A; Pedersen S; de la Morena-Barrio ME; Navarro-Fernández J; Kristensen SR; Miñano A; Padilla J; Vicente V; Corral J
Thromb Res; 2011 Feb; 127(2):154-60. PubMed ID: 21126754
[TBL] [Abstract][Full Text] [Related]
14. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
Rao LV; Rapaport SI
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6687-91. PubMed ID: 3261869
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragments.
Schoen P; Lindhout T; Willems G; Hemker HC
J Biol Chem; 1989 Jun; 264(17):10002-7. PubMed ID: 2722856
[TBL] [Abstract][Full Text] [Related]
16. The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III.
Hamamoto T; Kisiel W
Int J Hematol; 1998 Jul; 68(1):67-78. PubMed ID: 9713170
[TBL] [Abstract][Full Text] [Related]
17. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
Craig PA; Olson ST; Shore JD
J Biol Chem; 1989 Apr; 264(10):5452-61. PubMed ID: 2925612
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.
Jesty J; Wun TC; Lorenz A
Biochemistry; 1994 Oct; 33(42):12686-94. PubMed ID: 7918495
[TBL] [Abstract][Full Text] [Related]
19. The in situ inhibition of prothrombinase-formed human alpha-thrombin and meizothrombin(des F1) by antithrombin III and heparin.
Schoen P; Lindhout T
J Biol Chem; 1987 Aug; 262(23):11268-74. PubMed ID: 3611110
[TBL] [Abstract][Full Text] [Related]
20. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
Björquist P; Boström S
Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
